Placental physiology + amniotic fluid Flashcards
Placental metabolism
not passive
rapid growth in first trimester, size >fetus for 16 weeks
decreased growth rate during later pregnancy but extensive maturation - increased branching, decreased thickness, functionally increased surface area
Blood/energy supply to placenta via maternal uterine artery
Placenta uses more energy than fetus (1/2 O and 2/3 glucose delivered to uterus)
Synthesizes glycogen
Produces proteins/steroids
Active transport of some elements
Concurrent blood flow in placenta
maternal + fetal blood flow in the same direction
Both enter in arteries, both leave in veins (parallel transport)
Hemochorial placentation
fetal blood within chorionic villi
Villi bathed in maternal blood
Maternal blood propelled into intervillous space in jetlike streams travelling towards chorionci plate
Blood then percolates down around villi to maternal venous drainage
Gas exchange at the placenta
placental barrier highly permeable to oxygen and CO2
Rate, volume and pressure of blood flow to placenta is major rate determining factor
Maternal:fetal partial pressure also important
Maternal and fetal hemoglobin O2 affinity also important
Simple diffusion in placenta
common for substances with: - large gradient between mom and fetus - LMW - minimal electronic charge - high lipid solubility generally - O2, CO2, H2O
Facilitated diffusion in placenta
Glucose
Main fetal nutrient
Placenta doesn’t produce glucose until late gestation, so uptake of maternal glucose is essential
favourable gradient from mother to fetus
Facilitated diffusion with glucose receptors on placenta
- non-energy dependent, non-insulin dependent
- even more efficient than simple diffusion alone at ensuring adequate glucose supply to fetus
Pregnancy: relative insulin resistance –> increases glucose availability to fetus
Active transport in placenta
Amino acids:
- work against gradient
Lactate:
- large amounts of lactate produced by placental metabolism are transferred to maternal circulation by active transport
Endocytosis in placenta
IgG transfer
- very large
- no concentration gradient
- picked up by receptors at placental barrier
- IgG can also work against us - Rhesus hemolysis etc
Viruses
- likely that some viruses transfer to fetus
Leakage at placenta
Disruption in feto-maternal barrier
Occurs in normal pregnancies in small amount due to microtears at syncytiotrophoblastic barrier
Significant disruption/transfer can occur with abruptio placenta –> massive fetomaternal hemorrhage and fetal anemia/death
Ketone transfer at placenta
- used by fetus when glucose is low
- liposoluble, can cross by simple diffusion
Free FA transfer at placenta
- also used by fetus for energy when low glucose supply (starvation)
- some too large to cross
- essential FFA will cross slowly by simple diffusion
- possibly also some endocytosis
Drug transfer across placenta
depends on: size, charge, gradient, degree of drug protein binding, liposolubility
Many drugs cross in some amount, mostly by simple diffusion
Liposoluble drugs rapidly cross placenta - e.g. inhalational anesthetics
Large drug molecules will not cross (heparin, thyroxin replacement, insulin)
hCG
glycoprotein very similar to LH (same alpha subunit as LH, FSH, TSH; beta subunit unique but similar to LH)
produced almost exclusively by syncytiotrophoblast
Detectable in blood 8-9 d post-ovulation (blastocyst implantation)
Serum level doubles every 48 h, peak at 10 weeks, declines then plateaus
–> useful in following early pregnancy in patients with risk factors/complications
Actions of hCG
rescue/maintenance of corpus luteum (therefore progesterone production)
6 weeks: placenta takes over progesterone production
stimulates fetal testis production of testosterone
hPL
human placental lactogen
Produced by syncytiotrophoblasts (not exclusively)
proportional to placental mass
- production rises steadily until 34-36 weeks
- twins have higher hPL
Actions:
- supports nutritional needs of fetus
- fail-safe mechanism to ensure adequate nutrient supply to fetus especially in fasting state
hPL - maternal fasting state
lipolysis –> increased FFA (maternal energy) and ketones (fetal nutrition)
hPL - maternal fed state
anti-insulin
increased FFA interferes with insulin-directed entry of glucose into cells –> higher circulating glucose –> favours glucose transport to fetus –> gestational diabetes
Gestational diabetes
3-10% of all pregnancies
CH intolerance of variable severity with first onset/recognition during pregnancy
increased in twins due to higher hPL
Progesterone production during pregnancy
From maternal cholesterole
initially by corpus luteum
hCG rescue of CL ensures progesterone production by CL until 6-10 wks
Placental production of progesterone takes over at 6-10 weeks
Also some production by decidua and fetal membranes
Progesterone action during pregnancy
role in endometrial preparation/implantation
Maintain uterine quiescence during pregnancy “pro-gestation”
smooth muscle relaxation of uterus
inhibits uterine PG production (delays cervical ripening)
immunological modulation
Placental progesterone is pool of substrate for production of fetal adrenal corticosteroids
Estrogen production during pregnancy
from maternal androgens (in early pregnancy)
fetal androgens (later pregnancy)
by placenta
Estrogen action during pregnancy
increased uterine blood flow/CO
- peripheral v/d-
- regulates blood volume by stimulation of RAS
Uterine preparation for labour
Uterine contraction in labour
prepares breast for lactation
increase liver production of hormone-binding globulins
Corticosteroid production during pregnancy
by fetal adrenals from placental progesterone
Corticosteroid action during pregnancy
promotes fetal lung maturation
maternal fluid expansion (to fill estrogen-vasodilated vessels)